Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Express Scripts (ESRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,061,192
  • Shares Outstanding, K 563,860
  • Annual Sales, $ 100,065 M
  • Annual Income, $ 4,517 M
  • 36-Month Beta 0.88
  • Price/Sales 0.54
  • Price/Cash Flow 8.80
  • Price/Book 2.53
  • Price/Earnings ttm 11.17
  • Earnings Per Share ttm 8.58
  • Most Recent Earnings 2.43 on 10/31/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 2.67
  • Number of Estimates 10
  • High Estimate 2.77
  • Low Estimate 2.58
  • Prior Year 2.16
  • Growth Rate Est. (year over year) +23.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.11 +0.24%
on 12/20/18
101.73 -9.24%
on 12/03/18
-2.96 (-3.11%)
since 11/20/18
3-Month
91.92 +0.45%
on 10/24/18
101.73 -9.24%
on 12/03/18
-2.71 (-2.85%)
since 09/20/18
52-Week
66.93 +37.95%
on 04/02/18
101.73 -9.24%
on 12/03/18
+18.34 (+24.79%)
since 12/20/17

Most Recent Stories

More News
Express Scripts Canada Renews Contract with iA Financial Group

Express Scripts Canada secures enduring relationship with iA Financial Group to provide Claim Management Services

ESRX : 92.33 (-3.62%)
HIMSS '19: Data-Driven Tools from Cigna and Express Scripts Boost Access to Real-Time Prescription Savings Opportunities

--ScriptVision(TM) (beta) physician mobile application is a new addition to the Express Scripts suite of digital provider solutions to enable physicians and personalize care for patients.

ESRX : 92.33 (-3.62%)
CI : 193.77 (+0.99%)
RFPIO to Provide Enterprise-Wide Response Management Solution to Express Scripts

RFPIO, the leader in cloud-based RFP response management software, today announced that Express Scripts, part of Cigna Corporation, a health services leader that delivers personalized solutions to improve...

ESRX : 92.33 (-3.62%)
Express Scripts Saved Plans $45 Billion on Prescription Drugs in 2018

Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released...

ESRX : 92.33 (-3.62%)
Cigna Delivers Strong 2018 Results as it Completes Express Scripts Transaction; Company Positioned for Significant Growth

--Shareholders' net income for 2018 was $2.6 billion, or $10.54 per share

ESRX : 92.33 (-3.62%)
CI : 193.77 (+0.99%)
Photo of Cigna Building Blessings in a Backpack in Nashville Available on Business Wire's Website and the Associated Press Photo Network

A photo is available on Business Wire's website and the Associated Press photo network of Cigna and Express Scripts employees in Nashville celebrating the combination of their companies by...

ESRX : 92.33 (-3.62%)
CI : 193.77 (+0.99%)
Photo of Cigna Building Blessings in a Backpack in Orlando Available on Business Wire's Website and the Associated Press Photo Network

A photo is available on Business Wire's website and the Associated Press photo network of Cigna and Express Scripts employees in Orlando celebrating the combination of the two companies by...

ESRX : 92.33 (-3.62%)
CI : 193.77 (+0.99%)
Photo of Cigna Building Blessings in a Backpack in Phoenix Available on Business Wire's Website and the Associated Press Photo Network

A photo is available on Business Wire's website and the Associated Press photo network of Cigna and Express Scripts employees at the Cigna Norterra office celebrating the combination of the...

ESRX : 92.33 (-3.62%)
CI : 193.77 (+0.99%)
Photo of Cigna Building Blessings in a Backpack in Franklin Lakes, N.J. Available on Business Wire's Website and the Associated Press Photo Network; Food Going to Bronx, N.Y. School

A photo is available on Business Wire's website and the Associated Press photo network of employees at the Express Scripts office in Franklin Lakes, N.J. celebrating the company's combination...

ESRX : 92.33 (-3.62%)
CI : 193.77 (+0.99%)
Express Scripts Recognized for Supplier Diversity

Express Scripts, part of Cigna Corporation, was recently named "Corporation of the Year" for its commitment to sustainable strategic partnerships with minority business enterprises by the Mid-States Minority...

ESRX : 92.33 (-3.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ESRX with:

Business Summary

Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy...

See More

Key Turning Points

2nd Resistance Point 97.20
1st Resistance Point 94.76
Last Price 92.33
1st Support Level 91.00
2nd Support Level 89.68

See More

52-Week High 101.73
Last Price 92.33
Fibonacci 61.8% 88.44
Fibonacci 50% 84.33
Fibonacci 38.2% 80.22
52-Week Low 66.93

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar